Suppliers / Zhejiang Jiangbei Nanhai Pharmaceutical

Zhejiang Jiangbei Nanhai Pharmaceutical

China Updated 9 July 2026

Zhejiang Jiangbei Nanhai Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file and 6 valid CEPs across a filed portfolio of 5 molecules. Its GMP standing is certified by EMA.

1
active US DMFs
6
valid CEPs
2
registered plants
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Linhai City, China Not on file
Linhai, China Not on file

What they file, and where

Molecule Regulators Docs
Simvastatin EDQM, US FDA 3
Atorvastatin Calcium EDQM 1
Levetiracetam EDQM 1
Rosuvastatin Calcium EDQM 1
Ticagrelor EDQM 1

Also appears on these molecule pages

Simvastatin API Atorvastatin API Rosuvastatin API Levetiracetam API Ticagrelor API

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA None 1

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Jiangbei Nanhai Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates